Neuroimmunology and Glial Biology

Neuroimmunology and Glial Biology
Ari J. Green, MD, MCR - Division Chief

Covid-19 Info for Patients

Division of Neuroimmunology  org chart

Ahmed Abdelhak, MD
Katerina Akassoglou, PhD
Sergio Baranzini, PhD
Riley Bove, MD, MSc - Director, BRIDGE
Jonah Chan, PhD - Associate Division Chief
Bruce Cree, MD, PhD, MCR
Stephen Fancy, PhD, DVM
Jeffrey Gelfand, MD
Josiah Gerdts, MD
Douglas Goodin, MD
Ari J. Green, MD, MCR - Division Chief
Joanne Guo, MD - Fellowship Director
Sasha Gupta, MD
Stephen L. Hauser, MD - Director, UCSF Weill Institute
Roland Henry, PhD
Jill Hollenbach, PhD, MPH
Jorge Oksenberg, PhD
Lauren Oommen, DO
Nico Papinutto, PhD
Samuel Pleasure, MD, PhD
Joseph Sabatino, MD, PhD
Emmanuelle Waubant, MD, PhD
Michael Wilson, MD
Scott Zamvil, MD, PhD


See our list of individual laboratories in our division to review basic research programs.

Programs Within the Division

  • Small Molecule Remyelination - This is a Phase II, Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis - Ari Green, MD and Jonah Chan, PhD.
  • ORIGINSStephen L. Hauser, MD and Bruce Cree, MD, PhD (co-PIs).
  • Clinical Research - Find trials that are open for enrollment.
  • Microbiome - Investigating the role of gut bacteria (microbiota) and their genes (microbiome) in multiple sclerosis (MS) - Sergio Baranzini, PhD. Dr. Baranzini also leads the International MS Microbiome Study.
At the Actrims Forum 2020

Members of the Bove Lab presenting data on minimal transfer of rituximab into breastmilk of women with MS, offering a possible treatment option to high-risk women in the postpartum period.

Pictured L-R: Drs. Annika Andersen, Kirsten Krysko, and Alice Edwards.